Annual CFI
N/A
December 31, 2023
Summary
- PDSB annual cash flow from investing activities is not available.
Performance
PDSB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$0.00
+$29.00 K+100.00%
September 30, 2024
Summary
- As of February 8, 2025, PDSB quarterly cash flow from investing activities is $0.00, with the most recent change of +$29.00 thousand (+100.00%) on September 30, 2024.
- PDSB quarterly CFI is now -100.00% below its all-time high of $29.11 million, reached on March 31, 2019.
Performance
PDSB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$29.00 K
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, PDSB TTM cash flow from investing activities is -$29.00 thousand, unchanged on September 30, 2024.
- PDSB TTM CFI is now -100.10% below its all-time high of $29.38 million, reached on December 31, 2019.
Performance
PDSB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PDSB Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | 0.0% | -100.0% |
5 y5 years | - | 0.0% | -100.0% |
PDSB Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +100.0% | <-9999.0% | at low | ||
5 y | 5-year | -100.0% | +100.0% | -100.1% | at low | ||
alltime | all time | -100.0% | +100.0% | -100.1% | +97.8% |
PDS Biotechnology Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $0.00(-100.0%) | -$29.00 K(0.0%) |
Jun 2024 | - | -$29.00 K(<-9900.0%) | -$29.00 K(<-9900.0%) |
Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2023 | - | $0.00(-100.0%) | $0.00(-100.0%) |
Dec 2019 | $29.38 M(>+9900.0%) | $275.00 K(>+9900.0%) | $29.38 M(+0.9%) |
Sep 2019 | - | $0.00(0.0%) | $29.11 M(0.0%) |
Jun 2019 | - | $0.00(-100.0%) | $29.11 M(0.0%) |
Mar 2019 | - | $29.11 M(>+9900.0%) | $29.11 M(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
Sep 2018 | - | $0.00(0.0%) | -$28.00 K(-66.3%) |
Jun 2018 | - | $0.00(0.0%) | -$83.10 K(-16.5%) |
Mar 2018 | - | $0.00(-100.0%) | -$99.50 K(-47.3%) |
Dec 2017 | -$188.70 K | -$28.00 K(-49.2%) | -$188.80 K(-62.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | -$55.10 K(+236.0%) | -$508.10 K(-14.9%) |
Jun 2017 | - | -$16.40 K(-81.6%) | -$597.10 K(-14.5%) |
Mar 2017 | - | -$89.30 K(-74.3%) | -$698.70 K(+1.7%) |
Dec 2016 | -$686.70 K(-47.4%) | -$347.30 K(+141.0%) | -$686.70 K(-18.7%) |
Sep 2016 | - | -$144.10 K(+22.1%) | -$845.10 K(-19.8%) |
Jun 2016 | - | -$118.00 K(+52.7%) | -$1.05 M(-18.8%) |
Mar 2016 | - | -$77.30 K(-84.7%) | -$1.30 M(-0.7%) |
Dec 2015 | -$1.31 M(+47.5%) | -$505.70 K(+43.5%) | -$1.31 M(+63.3%) |
Sep 2015 | - | -$352.30 K(-2.4%) | -$799.50 K(+78.8%) |
Jun 2015 | - | -$361.10 K(+319.4%) | -$447.20 K(+419.4%) |
Mar 2015 | - | -$86.10 K | -$86.10 K |
Dec 2014 | -$884.80 K(+546.3%) | - | - |
Dec 2013 | -$136.90 K | - | - |
FAQ
- What is the all time high annual CFI for PDS Biotechnology?
- What is PDS Biotechnology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for PDS Biotechnology?
- What is PDS Biotechnology TTM cash flow from investing activities?
- What is the all time high TTM CFI for PDS Biotechnology?
What is the all time high annual CFI for PDS Biotechnology?
PDS Biotechnology all-time high annual cash flow from investing activities is $29.38 M
What is PDS Biotechnology quarterly cash flow from investing activities?
The current quarterly CFI of PDSB is $0.00
What is the all time high quarterly CFI for PDS Biotechnology?
PDS Biotechnology all-time high quarterly cash flow from investing activities is $29.11 M
What is PDS Biotechnology TTM cash flow from investing activities?
The current TTM CFI of PDSB is -$29.00 K
What is the all time high TTM CFI for PDS Biotechnology?
PDS Biotechnology all-time high TTM cash flow from investing activities is $29.38 M